Saccharide Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Saccharide Therapeutics General Information

Description

Developer of synthetic glycoconjugate vaccines intended to protect against deadly infectious diseases. The company is advancing a pipeline of synthetic glycoconjugate vaccines that target highly conserved elements across multiple pathogens, including malaria, tuberculosis, and invasive fungal infections, enabling global health organizations to access novel synthetic vaccines designed to provide high levels of protection against major global pathogens.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Southbank, Victoria
  • Australia
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Southbank, Victoria
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Saccharide Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Sep-2026 Completed Clinical Trials - Phase 1
1. Early Stage VC Completed Clinical Trials - Phase 1
To view Saccharide Therapeutics’s complete valuation and funding history, request access »

Saccharide Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Saccharide Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biointelect Accelerator/Incubator
La Ferla Ventures Venture Capital Minority
To view Saccharide Therapeutics’s complete investors history, request access »

Saccharide Therapeutics FAQs

  • When was Saccharide Therapeutics founded?

    Saccharide Therapeutics was founded in 2024.

  • Where is Saccharide Therapeutics headquartered?

    Saccharide Therapeutics is headquartered in Southbank, Australia.

  • What is the size of Saccharide Therapeutics?

    Saccharide Therapeutics has 2 total employees.

  • What industry is Saccharide Therapeutics in?

    Saccharide Therapeutics’s primary industry is Biotechnology.

  • Is Saccharide Therapeutics a private or public company?

    Saccharide Therapeutics is a Private company.

  • What is Saccharide Therapeutics’s current revenue?

    The current revenue for Saccharide Therapeutics is .

  • Who are Saccharide Therapeutics’s investors?

    Biointelect and La Ferla Ventures have invested in Saccharide Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process